We describe a case of a 70-year-old male who came to the emergency room due to dyspnea and cough despite antibiotic therapy for about one week. Chest X-ray showed moderate right pleural effusion associated with signs of pulmonary stasis and calcifications of the aorta. His history included hypertension (treated with beta-blockers) smoking and alcohol abuse. The patient was transferred to our Department and was started on therapy with boluses of intravenous diuretics. An ARB was introduced for better blood pressure control and progressive improvement of dyspnea. However, during hospitalization, the patient had an onset of angina with evidence of ST depression and onset of negative T waves in V5-V6 on electrocardiogram performed. He was submitted to trans thoracic echocardiogram which showed a dilated left ventricle with akinesia of the anterior and inferior mid-basal segments and basal septal walls determining moderate global systolic dysfunction (ejection fraction 35%-40%) and evidence of aortic stenosis. There was a modest increase in the markers of myocardial necrosis. So we began double antiplatelet therapy and intravenous nitrates added to 20 mg of simvastatin and it was planned the coronary angiography. Meanwhile, for the detection of marked bradycardia and some episodes of asystole on telemetry ( Figure 1 ) the patient was transferred to our intensive care unit and it was implanted temporary pacemaker. Coronary angiography detected moderate coronary artery disease: moderate stenosis of the proximal left anterior descending coronary and to ostial of right coronary artery (RCA); before a revascularization procedure we planned a study of myocardial viability in the territory of the RCA. Returning from the hemodynamic room the patient reported the onset of temporary phosphenes in the right eye. He was evaluated by a neurologist who suggested a retinal periprocedural microembolism. Another echocardiogram was performed which confirmed what had been revealed earlier. However moderate aortic calcified stenosis was noted (delta P max 35-40 mm Hg, AVA 1.5 -1.6 cm2), subsequently confirmed by transesophageal echocardiograpy (TEE) (Figure 2 ). It also showed the presence of a marked atherosclerotic aortic wall associated with moving parts floating in the descending aorta that were not present in the aortic arch ( Figure  3) . The patient was treated with heparin, enhanced antihypertensive therapy and simvastatin was replaced with 40 mg of atorvastatin. Due to the onset of inflammation, the assessment for possible revascularization and implantation of pacemaker was delayed. During the subsequent hospitalization, the patient began complaining of a stabbing pain and cramping of the left lower limb, associated with absence of peripheral pulses and hypothermia. A vascular surgeon was contacted who raised the suspicion of acute lower limb thrombotic and embolic ischemia. The patient underwent thromboembolectomy using a Fogarty catheter followed by resumption of anticoagulation.
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After a few hours we noted the emergence of an acute ischemia of the right leg. The surgeon was again contacted and he gave an indication for angiography with evidence of obstruction at the common femoral artery. So the patient underwent thromboembolectomy at the femoral bifurcation with profundoplasty with a bovine patch and right superficial femoral A drastic complex atheromatous aorta A case report Ateromasia aortica complicata. Un caso clinico internal carotid artery thrombosis and hyperacute ischemia in the territory of the middle cerebral artery (recanalized by the oars of the Willis polygon). Given the poor prognosis and the framework itself there was no indication for intensive treatment. artery ligation. Upon return from the operating room, the patient showed no signs of bilateral flow and he resumed heparin therapy. In the following hours he suddenly became comatose; angio-computed tomography was performed showing the evidence of right the plaque, such as ulceration or the presence of thrombi, is associated with increased embolic risk, while the presence of calcification indicates a lower risk. Plaque morphology is very dynamic with frequent formations and resolution of mobile components [2] . In the literature, the embolic risk associated with AA was significant if placque thickness was greater than 4 mm and if it was complex (e.g. moving parts increase the risk of stroke and death by 17-fold). AA is often associated with atherosclerosis in other vascular beds such as the carotid artery and coronary arteries [3] ; an association with severe calcific aortic stenosis and mitral annular calcification has also been observed. These conditions are predisposed to embolisms and therefore aortic atheroma may be a marker of other disease states causing stroke [4, 5] . In particular, the simultaneous presence of atherosclerotic aortic and aortic valve stenosis has been increasingly recognized [6] ; At our institution we noted that 63% of patients with aortic valve stenosis had severe aortic atheromatous plaque (> 4 mm) compared to 35% with mild aortic stenosis.
Discussion
Aortic atherosclerosis
It has been estimated that the relative risk for stroke or peripheral embolism in patients with severe AA has quadrupled and is even more than 12 in patients with mobile atheromas and fluctuating components; its prevalence among patients presenting with ischemic stroke is similar to that of atrial fibrillation and atheromatous carotid (20%). Recurrent stroke is common in patients with aortic arch atheroma with a thickness of more than 4 mm or mobile components, particularly in the categories of high-risk patients such as the elderly, smokers, hypertensives and diabetics. Patients who have severe and complex atheroma are at increased risk of recurrence (14% per year) and could therefore require a more aggressive secondary prevention strategy. The increasing use of TEE has enhanced the recognition of aortic atheromas. In patients with cryptogenetic stroke, it is reasonable to verify the presence of a severe and complex aortic atheroma by the use of TEE [7] . Although magnetic resonance and computed tomography investigations are emerging non-invasive diagnoses for characterization of aortic atheromas, TEE is still a high-level investigation [8, 9] .
AA treatment has not yet been well defined and there are still conflicting results regarding the use of anticoagulant. Statins, by their mechanisms of plaque stabilization, appear to be a promising approach [10, 11] . Surgical treatment should be considered for patients with abdominal aortic or popliteal artery aneurysms and downstream atheroembolism. There are case reports of atheroemboli in patients worsening after being given warfarin or heparin. For this reason, some institutions are reluctant to prescribe these drugs for patients with atheroemboli or thromboemboli from aortic plaque. However, the incidence of this complication is quite low. Anticoagulation should probably be stopped if a patient develops an atheroembolism. Unstable aortic plaques may develop superimposed thrombi, easily seen as mobile elements on TEE. Therefore, it is possible that anticoagulation with warfarin might prevent embolic events in these patients. Currently, the combination of dual antiplatelet therapy or anticoagulation with warfarin are used. Which of these two treatments are more effective will be evident after the end of the study ARCH (Aortic Arch Related Cerebral Hazard trial) [12] .
In the described case it should be noted that neither the introduction of high-dose statin therapy nor the use of dual antiplatelet and anticoagulant therapy changed the prognosis of the patient.
